Target intelligence / Profile preview

Ferritin light chain pseudogene 4 (FTLP4)

Target: FTLP4
Molecular classification: Pseudogene

Overview

FTLP4 (Ferritin light chain pseudogene 4) is an unprocessed pseudogene in the human genome that shares sequence similarity with the functional ferritin light chain (FTL) protein-coding gene. Unlike FTL, FTLP4 does not produce a protein and has no characterized biological, disease, or pharmacological functions. This pseudogene may be annotated in genomic databases due to sequence resemblance but is not a subject for therapeutic intervention. Diseases such as neuroferritinopathy or hyperferritinemia-cataract syndrome are associated with the functional FTL gene, not FTLP4.

Mechanism of action

None

Beyond the preview

Go deeper on Ferritin light chain pseudogene 4 (FTLP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferritin light chain pseudogene 4 (FTLP4).

Explore the full profile